Buscar resultados de ensayos clínicos
Leukemia, Prolymphocytic - 55 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) Condición: T-cell-prolymphocytic Leukemia Fecha: 2010-08-20 Intervenciones:
|
Terminated |
Nombre del estudio: Fludarabine, Cyclophosphamide, and Rituximab in Treating Patients With Prolymphocytic Leukemia Condición: Prolymphocytic Leukemia Fecha: 2006-01-24 Intervenciones:
|
Completed |
Nombre del estudio: Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condición: Prolymphocytic Leukemia Fecha: 2006-01-16 Intervenciones:
|
Terminated |
Nombre del estudio: Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condición:
Intervenciones: Drug: alvocidib Other Names: |
Active, not recruiting |
Nombre del estudio: PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia Condición:
|
Completed |
Nombre del estudio: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) Condición:
|
Terminated |
Nombre del estudio: Alvespimycin Hydrochloride in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-Cell Prolymphocytic Leukemia Condición:
Intervenciones: |
Terminated |
Nombre del estudio: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia Condición:
|
Terminated |
Nombre del estudio: 17-N-Allylamino-17-Demethoxygeldanamycin With or Without Rituximab in Treating Patients With Relapsed B-Cell Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Condición:
Intervenciones: |
Withdrawn |
Nombre del estudio: Phase II Study of VELCADE for Relapsed or Refractory T-cell Prolymphocytic Leukemia Condición:
Fecha: 2010-07-12 Intervenciones: Drug: Velcade IV Other Name: Bortezomib |